Cafepharma Today

June 7 2023 - Study: Biosimilars ‘fulfilling their promise’ of lowering biologic prices
Study: Biosimilars ‘fulfilling their promise’ of lowering biologic prices
After Merck's flashpoint IRA lawsuit, Biogen CEO and others register their own complaints
Zuckerberg cash helping to propel Chicago's biotech ambitions
GSK’s RSV vaccine wins European approval
*please scroll down for all the latest news*

Current News

submit a press release

Click here to stay updated on CP happenings
Bayer's acting BD chief lobbies for the job the only way he knows how: by making deals
Fierce Biotech
Wednesday, May 24, 2023 - 10:23am
tags:
Bayer, business development
Why Is CVS Health Clinical Trial Services Closing?
Xtalks
Wednesday, May 24, 2023 - 10:21am
tags:
CVS Health, clinical trials
Novo makes a gene editing move
EP Vantage
Wednesday, May 24, 2023 - 10:20am
tags:
Novo Nordisk, gene editing, Life Edit Therapeutics
How tranScrip CEO Marcin Mankowski is ‘driving forward’ drug innovation and development
Biopharma Reporter
Wednesday, May 24, 2023 - 10:16am
tags:
drug development, tranScrip, innovation
Merck’s Gardasil Under Legal Scrutiny Despite Lack of Evidence to Support Suits
BioSpace
Wednesday, May 24, 2023 - 10:15am
tags:
Merck, vaccines, Gardasil, legal, HPV, side effects
Rain Oncology Plummets after Lead Candidate Disappoints in Phase 3
Tip Ranks
Wednesday, May 24, 2023 - 10:14am
tags:
Rain Oncology, liposarcoma, clinical trials, milademetan
Bayer, Amgen looked at Iveric before agreeing to Astellas sale
Seeking Alpha
Tuesday, May 23, 2023 - 6:20pm
tags:
Astellas, Iveric Bio, Bayer, Amgen, M&A
Orthopedic markets to return to normal this year as post-pandemic boost fades: analysts
Medtech Dive
Tuesday, May 23, 2023 - 6:17pm
tags:
Medtech, Orthopedics, pandemic, COVID-19
Amgen settles patent lawsuit over biosimilar of J&J's big-selling Stelara
Yahoo/Reuters
Tuesday, May 23, 2023 - 6:14pm
tags:
JNJ, Amgen, patents, Stelara, biosimilars, legal
Bristol Myers Squibb eyes phase 3 after pulmonary fibrosis drug reduces lung function decline
Fierce Biotech
Tuesday, May 23, 2023 - 6:12pm
tags:
Bristol Myers Squibb, clinical trials, BMS-986278, idiopathic pulmonary fibrosis
Top three unmet needs to target in Parkinson’s disease
Clinical Trials Arena
Tuesday, May 23, 2023 - 6:08pm
tags:
Parkinson's Disease, drug devlopment
2 small biotechs morph to work on oncology together
Fierce Biotech
Tuesday, May 23, 2023 - 6:07pm
tags:
CohBar, Morphogenesis, TuHURA Biosciences, immuno-oncology
Wave's ALS-dementia drug crashes out after early-phase flop, dealing further blow to target
Fierce Biotech
Tuesday, May 23, 2023 - 11:41am
tags:
Wave Life Sciences, antisense, WVE-004, clinical trials, ALS, dementia
Larkspur Biosciences Launches with $35.5 Million in Financing to Build the Next Precision Immunotherapies to Outsmart Cancer
Globe Newswire
Tuesday, May 23, 2023 - 11:40am
tags:
Larkspur Biosciences, immunotherapy, cancer, funding
Roche Terminates Second Phase II Schizophrenia Trial
BioSpace
Tuesday, May 23, 2023 - 11:24am
tags:
Roche, schizophrenia, ralmitaront, clinical trials
Affimed reveals 25% of staff were laid off in April in wake of phase 2 lymphoma fail
Fierce Biotech
Tuesday, May 23, 2023 - 11:22am
tags:
Affimed, layoffs, lymphoma
Pfizer Stock Jumps After Diabetes Drug Tops Ozempic In Weight Loss
Investors Business Daily
Tuesday, May 23, 2023 - 11:19am
tags:
Pfizer, Novo Nordisk, weight loss, Ozempic, danuglipron, clinical trials
Achieve's anti-smoking drug beats placebo in 2nd phase 3, keeping biotech on course for FDA filing
Fierce Biotech
Tuesday, May 23, 2023 - 10:14am
tags:
Achieve Life Sciences, smoking cessation, cytisinicline, clinical trials
Immunovant Shares Touch 52-Week High After FDA Green Lights IMVT-1402 Study
Marketwatch
Tuesday, May 23, 2023 - 10:12am
tags:
Immunovant, immunology, IMVT-1402, autoimmune disease, FDA
LabGenius utilizing machine learning to ‘transform’ cancer treatment
Biopharma Reporter
Tuesday, May 23, 2023 - 10:10am
tags:
LabGenius, machine learning, antibody discovery, artificial intelligence, cancer

Pages

Latest CP Wire Articles

Eastman introduces new excipient to formulate poorly soluble API
Most-clicked pharma news for week ending April 1 2023: Signify Health acquisition, Ferring Research Institute shutdown, Jardiance sales increase, and more
PharmaBlock Receives 2023 ACS CMO Excellence in Green Chemistry Award
PharmaBlock Opens New R&D Facility in Pennsylvania ——Expanding Capacity to Deliver GMP Projects
Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy
Most-clicked pharma news for week ending March 18 2023: Medtronic offers early retirement package, Novartis to sell ophthalmological assets, and Pfizer tops list of drugs with price increases
Klick Health launches new healthcare venture studio
Medtech earnings reports: insights from major players' Q4 results
Key compliance issues for medtech firms transitioning to data-enabled solutions
Following FDA COVID vaccine advisory panel vote, Novavax is prepared to provide a revised vaccine

Latest Pharmagather Articles

Drug Pricing Restrictions: Oh Joy
In the Pipeline
Just Stick 'Em Together
In the Pipeline
Pharmacist Salaries and Employment in 2022: The Good Times Roll for Retail Pharmacists
Drug Channels
thINc’s Specialty Networks and Patient Support Services Summit
Drug Channels
The Drug Discount Ecosystem’s “Mission Critical”
Drug Channels
Fakin' It the Modern Way
In the Pipeline
Reduction of Tau
In the Pipeline
Timeless
In the Pipeline
Drug Channels News Roundup, May 2023: 340B Shame, OptumRx vs. Humira Biosimilars, ICER on White Bagging, Hospitals vs. Taxes, and Dr. G
Drug Channels

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information